On May 15, Alex Guiliano, CIO of Resonate Wealth Partners, joined BNN Bloomberg to suggest that valuations internationally ...

Novartis outlook for 2027 using current valuation, company guidance, institutional inputs, and scenario-based price ranges.

A lot of investors tend to think about the S&P 500 index as one giant monolith, but I think it becomes much more interesting ...

From broad domestic exposure to global pharma and biotech, these funds cover the healthcare sector's main themes.

When it comes to growth stocks, much of the attention often centers around tech. But there are potentially much better ...

Picture an excessively mobile middle-class family that does almost nothing but drive, traveling from New York City to Los Angeles and back again each week. Its gasoline bill, instead of taking up a ...

This episode was filmed Wednesday 6th May 2026. It starts with nothing. A minor ache here, an odd pain there. It lingers…strange, but not alarming enough to call the doctor. Not yet. So you make the ...

Nektar Therapeutics is significantly de-risked after positive Rezpeg phase 2 data in atopic dermatitis and alopecia areata, targeting multi-billion dollar markets. Rezpeg's strong safety profile, ...

Meta META2.09%increase; green up pointing triangle Platforms shares look like a stock-market steal. But their bargain-bin price is more of a warning about its uncertain prospects than an opportunity ...

Health care REITs can potentially help retirement investors unlock above-average cash flows with lower-than-average market ...

Mike Khouw, strategist at YieldMaxETFs, explains why he favors an options strategy for this healthcare giant. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and ...

Looking for top growth stocks to buy this month? I have got some great options for you to consider. The stocks I'm going to cover aren't highly overpriced tech stocks. Instead, they can prove to be ...